Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole and amoxicillin as adjuncts to SRP for periodontitis in type 2 diabetics
NCT02135952Phase 4
Key facts
- Status
- Unknown
- Start
- Sep 2011
- Primary completion
- Oct 2014
- Countries
- 1
- Sponsor
- Universidade Guarulhos
- Modality
- Small Molecules
- Conditions
- periodontitis
01
Overview
Phase 4, randomised, double-blind trial of metronidazole and amoxicillin in periodontitis, sponsored by Universidade Guarulhos. Primary endpoint: Changes in number of sites with probing depth >= 5 mm at 12 months. Status: unknown.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Type 2 diabetic patients (HbA1c 6.5-11%) with generalized chronic periodontitis, at least 15 teeth, and specific probing depth/attachment loss criteria.
04
Endpoints
Primary
Changes in number of sites with probing depth >= 5 mm
Beyond the preview
Go deeper on NCT02135952.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135952.